OrbiMed Genesis GP LLC, Director, 10% Owner at Terns Pharmaceuticals, Inc. (TERN), bought 275,862 shares at $7.25 ($2.0M) on 2022-12-23, disclosed to the SEC on 2022-12-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.25 | 137,931 | $1000K | 50.0% |
| 2 | $7.25 | 137,931 | $1.0M | 50.0% |
| Total | $7.25 avg | 275,862 | $2.0M | 100% |
| Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |
| KROS | SELL | 2024-08-15 | $11.0M | — | Filing → |
| TERN | SELL | 2024-07-17 | $562K | — | Filing → |